This inventor holds 3 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Acceleron Pharma Inc., Celgene Corporation. Active years: 2019-2022.
Company Filing History:
3 out of 172 
1 out of 561 
Years Active: 2019-2022
Title: Christopher Robert Rovaldi: Innovator in Anemia Treatment
Introduction
Christopher Robert Rovaldi is a notable inventor based in Swampscott, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of anemia. With a total of 3 patents, Rovaldi's work focuses on innovative methods to improve the health of patients suffering from various blood disorders.
Latest Patents
Rovaldi's latest patents include groundbreaking methods for treating anemia and related conditions. One of his patents, titled "Activin-ActRII antagonists and uses for treating anemia," outlines methods for treating anemia requiring red blood cell transfusion, low or intermediate-1-risk myelodysplastic syndromes (MDS), and non-proliferative chronic myelomonocytic leukemia (CMML) in mammals. This patent emphasizes the administration of Activin-ActRII signaling inhibitors to patients in need of treatment. Another significant patent, "Methods for treating myelodysplastic syndromes and sideroblastic anemias," provides compositions and methods for increasing red blood cell and hemoglobin levels in vertebrates, including humans. This patent aims to treat or prevent sideroblastic anemias and myelodysplastic syndromes, along with their associated complications.
Career Highlights
Throughout his career, Rovaldi has worked with prominent companies in the pharmaceutical industry. He has been associated with Acceleron Pharma Inc. and Celgene Corporation, where he has contributed to the development of innovative treatments. His expertise in the field has allowed him to make a lasting impact on the medical community.
Collaborations
Rovaldi has collaborated with esteemed colleagues, including Kenneth M Attie and Abderrahmane Laadem. These partnerships have further enhanced his research and development efforts in the field of anemia treatment.
Conclusion
Christopher Robert Rovaldi is a distinguished inventor whose work has advanced the treatment of anemia and related disorders. His innovative patents and collaborations with leading companies and professionals highlight his commitment to improving patient outcomes. Rovaldi's contributions continue to shape the future of medical treatments for blood disorders.